We are disciplined
negotiators
We are resilient
entrepreneurs
working tirelessly to
materialize dreams
We are dreamers
with a plan
presenting refreshed
perspectives and noble goals
We are disciplined
negotiators
We are resilient
entrepreneurs
working tirelessly to
materialize dreams
We are dreamers
with a plan
presenting refreshed
perspectives and noble goals
We are disciplined
negotiators
We are resilient
entrepreneurs
working tirelessly to
materialize dreams
We are dreamers
with a plan
presenting refreshed
perspectives and noble goals

General Partners

We are living proof of what hard work can accomplish. We’ve built businesses from the ground up and successfully navigated through all kinds of challenges. Our journey has taught us not to settle for the ordinary and to always chin up to the future.

General Partners

We are living proof of what hard work can accomplish. We’ve built businesses from the ground up and successfully navigated through all kinds of challenges. Our journey has taught us not to settle for the ordinary and to always chin up to the future.

General Partners

We are living proof of what hard work can accomplish. We’ve built businesses from the ground up and successfully navigated through all kinds of challenges. Our journey has taught us not to settle for the ordinary and to always chin up to the future.

Jeff Stephens

General Partner

Global markets expert focused on key positioning and investment strategies.
Infusion 51a Co-founder and Chief Investment Officer. International Infusion Co-founder.
Managing Member of the General Partner and the Investment Advisor. Vivacitas Co-founder & Director. Former Theralink Director.

Scott VanderMeer, MBA

General Partner

Strategic investments and portfolio expansion. Infusion 51a Co-founder and Chief Financial Officer. International Infusion Co-founder. Managing Member of the General Partner and the Investment Advisor. Vivacitas Co-founder, Director & Interim CFO. Former Theralink Interim CFO.

Jeff Stephens

General Partner

Global markets expert focused on key positioning and investment strategies.
Infusion 51a Co-founder and Chief Executive Officer. International Infusion Co-founder.
Managing Member of the General Partner and the Investment Advisor. Vivacitas Co-founder &
Former Theralink Director.

Scott VanderMeer, MBA

General Partner

Strategic investments. portfolio expansion. Business marketing and Real Estate specialist.
Infusion 51a Co-founder. International Infusion Co-founder and Chair of the Global Development division. Vivacitas Co-founder, Director & Interim CFO. Former Theralink Interim CFO.

Strategic Advisors

One’s strength is nothing compared to joint efforts. Strategic alliances are our power unit.

Strategic Advisors

One’s strength is nothing compared to joint efforts. Strategic alliances are our power unit.

Strategic Advisors

One’s strength is nothing compared to joint efforts. Strategic alliances are our power unit.

Chan Heng Fai

Strategic Advisor

Leading financial advisor with +40 years of experience in corporate
restructuring, with a personal portfolio of +35 companies worldwide. Game changer and unicorn maker.

Afshin Safavi, PhD.

Strategic Advisor

Doctorate in Biochemistry. Founder, consultant, board member, entrepreneur, and investor in biotechnology, pharmaceutical, animal health, technology, and healthcare-related real estate.

Founder and former CSO of BioAgilytix Labs. Worked in small and large pharmaceutical, biotechnology, and manufacturing companies, including GSK and Bayer. Councilman for Cherry Hills Village, CO

Chan Heng Fai

Leading financial advisor with +40 years of experience in corporate
restructuring, with a personal portfolio of +35 companies worldwide. Game changer and unicorn maker.

Afshin Safavi, PhD.

Advisor

Ph.D. in Biochemistry. Founder and investor in biotechnology, pharmaceutical, IT-technology and real-estate sectors. Founder and former CSO of BioAgilytix Labs and Director of Ligand
Binding and Immunoassay at AAIPharma. Councilman for Cherry Hills Village, CO

Fund and Portfolio Operations

Beyond the steering wheel and the driver, there is a whole technical system that makes the car move.

Fund and Portfolio Operations

Beyond the steering wheel and the driver, there is a whole technical system that makes the car move.

Fund and Portfolio Operations

Beyond the steering wheel and the driver, there is a whole technical system that makes the car move.

Elise Brownell

Program Planning and Integration Director at Vivacitas Oncology

Executive Vice President of Operations and Project Management for the various pharmaceutical companies with +35 years of experience in biopharmaceutics. Founding team member of Aerovance, Inc. which garnered over $60 MUSD, and completed six clinical trials in 3.5 years.

Brett Logan, JD

Securities Counsel

Investment management attorney with 20 years of practice focused on hedge funds, private equity funds, fund of funds, real estate funds and investment advisors.

Hamed Reyhanfard, PharmD, EMBA

Director of Fund Development

Doctorate of Pharmacy, EMBA and MSc in Biochemistry and Chemistry with focus on the drug development in cancer therapy and solid tumor. +8 years of experience in strategic business development, Sales/commercials and Medical with Johnson & Johnson, Janssen Biotech, Chimeron Bio and OnsetCapital Partners and active fundraising for pharmaceutical Start-ups and other sectors in the US, Europe and Middle East.

Elise Brownell

Program Planning and Integration Director at Vivacitas Oncology

Executive Vice President of Operations and Project Management for the various pharmaceutical companies with +35 years of experience in biopharmaceutics. Founding team member of Aerovance, Inc. which garnered over $60 MUSD, and completed six clinical trials in 3.5 years.

Brett Logan, JD

Securities Counsel

Investment management attorney with 20 years of practice focused on hedge funds, private equity funds, fund of funds, real estate funds and investment advisors.

Hamed Reyhanfard, PharmD, EMBA

Director of Fund Development

Doctorate of Pharmacy, EMBA and MSc in Biochemistry and Chemistry with focus on the drug development in cancer therapy and solid tumor. +8 years of experience in strategic business development, Sales/commercials and Medical with Johnson & Johnson, Janssen Biotech, Chimeron Bio and OnsetCapital Partners and active fundraising for pharmaceutical Start-ups and other sectors in the US, Europe and Middle East.

Hong Li, MBA

Account Manager

MBA in Business Administration and Bachelor in Pharmaceutical Engineering with experience in the Pharmaceutical Industry, public and private hospitals, and start-up environment and good command of marketing, sales, business operations, training and coaching.

Jeffrey Busch

Theralink Chairman

Successful entrepreneur and active investor in various asset classes, including medical and pharmaceutical since 1985. Current Chairman and CEO $300MM exit to GlaxoSmithKline.
Served on George Bush Sr. Administration.

Krishn Patel

Director of Data Collection

Market research, online lead generation and data mining specialist with experience in different industries like Finance, Technology, Real Estate and Healthcare, in charge of developing new
technology tools and B2B marketing solutions.

Hong Li, MBA

Account Manager

MBA in Business Administration and Bachelor in Pharmaceutical Engineering with experience in the Pharmaceutical Industry, public and private hospitals, and start-up environment and good command of marketing, sales, business operations, training and coaching.

Jeffrey Busch

Theralink Chairman

Successful entrepreneur and active investor in various asset classes, including medical and pharmaceutical since 1985. Current Chairman and CEO $300MM exit to GlaxoSmithKline.
Served on George Bush Sr. Administration.

Krishn Patel

Director of Data Collection

Market research, online lead generation and data mining specialist with experience in different industries like Finance, Technology, Real Estate and Healthcare, in charge of developing new
technology tools and B2B marketing solutions.

Manuel Noriega

Director of Statistics and AI

Production Engineer, Data Scientist, Business Intelligence and Process Management Specialist
with +7 years of experience developing management solutions in large, medium and small
companies, thriving company equity growth and expansion of economic activities.

Maria Montilla

Director of Communications

Multimedia journalist with +5 years of proven work, with experience in VC and start-ups
corporative communications, advertising strategy, trend spotting and forecasting and data storytelling. BA in Mass Communications and MA in Political Communication.

Mark Suseck

CEO and Director of Vivacitas Oncology

+30 years of experience raising capital and implementing successful expansion strategies in the Biotech, Pharmaceutical, and MedTech industries. Mark has worked in large, diversified healthcare companies such as Johnson & Johnson and Sanofi S.A. and private equity and startup enterprises.

Manuel Noriega

Director of Statistics and AI

Production Engineer, Data Scientist, Business Intelligence and Process Management Specialist
with +7 years of experience developing management solutions in large, medium and small
companies, thriving company equity growth and expansion of economic activities.

Maria Montilla

Director of Communications

Multimedia journalist with +5 years of proven work, with experience in VC and start-ups
corporative communications, advertising strategy, trend spotting and forecasting and data storytelling. BA in Mass Communications and MA in Political Communication.

Mark Suseck

CEO and Director of Vivacitas Oncology

+30 years of experience raising capital and implementing successful expansion strategies in the Biotech, Pharmaceutical, and MedTech industries. Mark has worked in large, diversified healthcare companies such as Johnson & Johnson and Sanofi S.A. and private equity and startup enterprises.

Mick Ruxin, M.D

President, CEO and Director of Theralink Technologies

Prior Chairman, CEO and Founder of Global Med Technologies, Inc. (GLOB) serving over 30 countries on 4 continents, sold for $74M in public offering. One of the first 10 certified Medical
Review Officers in the country.

Monica Coleman, CPA

Finance Consultant

Fractional CFO at Chimeron Bio. +30 years of financial expertise with extensive experience with
cash flow optimization, budget creation and administration, due diligence, contract
negotiations, P&L accountability and ERP

Peter Seperack, PhD, JD

Director at Intellectual Property at Vivacitas Oncology

Ph.D. in Cellular and Developmental Biology. +30 years as a biopharmaceutical researcher and as a Biotech patent attorney. Developer of various molecular medicine breakthroughs,
including the discovery of molecular mechanism of a murine coat color mutation.

Mick Ruxin, M.D

President, CEO and Director of Theralink Technologies

Prior Chairman, CEO and Founder of Global Med Technologies, Inc. (GLOB) serving over 30 countries on 4 continents, sold for $74M in public offering. One of the first 10 certified Medical
Review Officers in the country.

Monica Coleman, CPA

Finance Consultant

Fractional CFO at Chimeron Bio. +30 years of financial expertise with extensive experience with
cash flow optimization, budget creation and administration, due diligence, contract
negotiations, P&L accountability and ERP

Peter Seperack, PhD, JD

Director at Intellectual Property at Vivacitas Oncology

Ph.D. in Cellular and Developmental Biology. +30 years as a biopharmaceutical researcher and as a Biotech patent attorney. Developer of various molecular medicine breakthroughs,
including the discovery of molecular mechanism of a murine coat color mutation.

Todd Smith, MBA

Chief Commercial Officer

Senior pharmaceutical executive and board member with +25 years of medical device and
biotechnology leadership and long track record of building companies and achieving commercial and business development excellence. Current President and CEO of Assertio, Director for Vault Nano and Board Member at BVI Medical.

Todd Smith, MBA

Chief Commercial Officer

Senior pharmaceutical executive and board member with +25 years of medical device and
biotechnology leadership and long track record of building companies and achieving commercial and business development excellence. Current President and CEO of Assertio, Director for Vault Nano and Board Member at BVI Medical.

Scientific and Medical Advisors

Our consultants are globally recognized industry veterans whose experience spans up to four decades, serving as a source of unsurpassed wisdom and strategic thinking.

Scientific and Medical Advisors

Our consultants are globally recognized industry veterans whose experience spans up to four decades, serving as a source of unsurpassed wisdom and strategic thinking.

Scientific and Medical Advisors

Our consultants are globally recognized industry veterans whose experience spans up to four decades, serving as a source of unsurpassed wisdom and strategic thinking.

Amir Baluch, MD

Medical Advisor

BS Biochemistry. Experience physician and investor Member of the Forbes Dallas Business
Council. Best Selling Author, Investing and Passive Income Consultant. Former BioWise Capital
Biotech Hedge Fund Manager.

Bill Coleman

Scientific Advisor

PhD in Biochemestry. Executive Officer at American Society for Investigative Pathology. +20 years of experience as a professor in the University of North Carolina, both in the Department of Pathology and Laboratory Medicine and as a director of Graduate Studies, Molecular and
Cellular Pathology Graduate Program.

Cory Hogue, MD

There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which look even slightly believable. If you are going to use a passage of Lorem Ipsum, you need to be sure there is anything embarrassing hidden in the middle of text. All the Lorem Ipsum generators on the Internet tend to repeat predefined chunks as necessary, making this the first true generator on the Internet. It uses a dictionary of over 200 Latin words, combined with a handful of model sentence structures, to generate Lorem Ipsum which looks reasonable. The generated Lorem Ipsum is therefore always free from repetition, injected humour, or non-characteristic words etc.Contrary to popular belief, Lorem Ipsum is not simply random text. It has roots in a piece of classical Latin literature from 45 BC, making it over 2000 years old. Richard McClintock, a Latin professor at Hampden-Sydney College in Virginia, looked up one of the more obscure Latin words, consectetur, from a Lorem Ipsum passage, and going through the cites of the word in classical literature, discovered the undoubtable source.

Amir Baluch, MD

Medical Advisor

BS Biochemistry. Experience physician and investor Member of the Forbes Dallas Business
Council. Best Selling Author, Investing and Passive Income Consultant. Former BioWise Capital
Biotech Hedge Fund Manager.

Bill Coleman

Scientific Advisor

PhD in Biochemestry. Executive Officer at American Society for Investigative Pathology. +20 years of experience as a professor in the University of North Carolina, both in the Department of Pathology and Laboratory Medicine and as a director of Graduate Studies, Molecular and
Cellular Pathology Graduate Program.

Cory Hogue, MD

There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which look even slightly believable. If you are going to use a passage of Lorem Ipsum, you need to be sure there is anything embarrassing hidden in the middle of text. All the Lorem Ipsum generators on the Internet tend to repeat predefined chunks as necessary, making this the first true generator on the Internet. It uses a dictionary of over 200 Latin words, combined with a handful of model sentence structures, to generate Lorem Ipsum which looks reasonable. The generated Lorem Ipsum is therefore always free from repetition, injected humour, or non-characteristic words etc.Contrary to popular belief, Lorem Ipsum is not simply random text. It has roots in a piece of classical Latin literature from 45 BC, making it over 2000 years old. Richard McClintock, a Latin professor at Hampden-Sydney College in Virginia, looked up one of the more obscure Latin words, consectetur, from a Lorem Ipsum passage, and going through the cites of the word in classical literature, discovered the undoubtable source.

David Mahvi, MD, FACS

Medical Advisor

Internationally acclaimed healthcare executive, surgeon, and medical engineering expert with 25+ years of experience. Former Chair of the American Board of Surgery. Author of 100+ academic articles on cancer-related topics.

Emmanuel Petricoin, PhD

Scientific Advisor​

PhD. In Microbiology. Professor & Co-Director of the Center for Applied Proteomics and
Molecular Medicine (CAPMM) at George Mason University. Co-founder of 4 life science
companies in the nanotechnology diagnostic and precision medicine space. Co-authored nearly
400 publications, and is a co-inventor on 40 filed and published patents.

Justin Davis, PhD

Laboratory Director at Theralink Technologies

Ph.D. in Biochemistry. Research Assistant Professor at the Center for Applied Proteomics and Molecular Medicine focused on the RPPA technology and protein signaling, with publications spanning topics of glioblastoma tumor heterogeneity and evolving RPPA technology and its
applications.

David Mahvi, MD, FACS

Medical Advisor

Internationally acclaimed healthcare executive, surgeon, and medical engineering expert with 25+ years of experience. Former Chair of the American Board of Surgery. Author of 100+ academic articles on cancer-related topics.

Emmanuel Petricoin, PhD

Scientific Advisor​

PhD. In Microbiology. Professor & Co-Director of the Center for Applied Proteomics and
Molecular Medicine (CAPMM) at George Mason University. Co-founder of 4 life science
companies in the nanotechnology diagnostic and precision medicine space. Co-authored nearly
400 publications, and is a co-inventor on 40 filed and published patents.

Justin Davis, PhD

Laboratory Director at Theralink Technologies

Ph.D. in Biochemistry. Research Assistant Professor at the Center for Applied Proteomics and Molecular Medicine focused on the RPPA technology and protein signaling, with publications spanning topics of glioblastoma tumor heterogeneity and evolving RPPA technology and its
applications.

Paul Manley, BSc

Regulatory Advisor

40+ years business expertise; 30+ years in Regulatory Affairs and Drug Development across a range of therapeutic areas in small and large pharma, Due Diligence for new or expanded
ventures specialist. Former Vice President, Global Oncology Regulatory Affairs at Johnson & Johnson. Current President & Principal Consultant at Orvieto Consulting, LLC.

Stefan Proniuk PhD, MBA

Product Development Advisor

PhD in Pharmaceutical Sciences. MBA in Entrepreneurship. Pharmaceutical Executive with 20+ years of industry experience. Leading clinical development programs from drug discovery to
commercialization. Current Chief Development Officer at Neuraptive Therapeutics.

Paul Manley, BSc

Regulatory Advisor

40+ years business expertise; 30+ years in Regulatory Affairs and Drug Development across a range of therapeutic areas in small and large pharma, Due Diligence for new or expanded
ventures specialist. Former Vice President, Global Oncology Regulatory Affairs at Johnson & Johnson. Current President & Principal Consultant at Orvieto Consulting, LLC.

Stefan Proniuk PhD, MBA

Product Development Advisor

PhD in Pharmaceutical Sciences. MBA in Entrepreneurship. Pharmaceutical Executive with 20+ years of industry experience. Leading clinical development programs from drug discovery to
commercialization. Current Chief Development Officer at Neuraptive Therapeutics.